Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Operating Expenses (2016 - 2025)

Avanos Medical's Operating Expenses history spans 12 years, with the latest figure at $81.5 million for Q3 2024.

  • For Q3 2024, Operating Expenses fell 3.89% year-over-year to $81.5 million; the TTM value through Dec 2024 reached $259.3 million, down 28.41%, while the annual FY2023 figure was $362.2 million, 1.83% up from the prior year.
  • Operating Expenses for Q3 2024 was $81.5 million at Avanos Medical, down from $87.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $100.5 million in Q1 2020 and bottomed at $66.1 million in Q4 2021.
  • The 5-year median for Operating Expenses is $85.4 million (2022), against an average of $87.4 million.
  • The largest annual shift saw Operating Expenses fell 28.0% in 2021 before it rose 28.59% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $91.8 million in 2020, then fell by 28.0% to $66.1 million in 2021, then rose by 28.59% to $85.0 million in 2022, then fell by 4.35% to $81.3 million in 2023, then grew by 0.25% to $81.5 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Operating Expenses are $81.5 million (Q3 2024), $87.2 million (Q2 2024), and $90.6 million (Q1 2024).